Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Can quantitative hepatitis B surface antigen levels predict the severity of liver disease in genotype E Patients?

Journal of viral hepatitis - 1 Jan 2018

Chakrabarty Gayatri, Bruce Matthew, Horner Mary, Wang Bo, Agarwal Kosh, Carey Ivana

Abstract excerpt

The utility of quantitative Hepatitis B surface antigen (qHBsAg) level as a marker of chronic hepatitis B (CHB)-related liver damage is not fully delineated, but is becoming increasingly relevant. Quantitative HBsAg levels are linked with progression of liver disease in HBeAg-negative genotype B and C patients, but it is not clear whether this is consistent across all HBV genotypes. In this single-centre,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Biopsy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B, Chronic

Share to Hepatitis B Surface Antigens

Share to Hepatitis B virus

Share to Histocytochemistry

Share to Liver Cirrhosis

Share to Viral Load

Source

Identifiers

PMID: 28710798
DOI: 10.1111/jvh.12756

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Can quantitative hepatitis B surface antigen levels predict the severity of liver disease in genotype E Patients?PMID 28710798Read ↗

Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients.Semantic proximity Read ↗

Serum Levels of Hepatitis B Surface Antigen Predict Severity of Fibrosis in Patients With E Antigen-Positive Chronic Hepatitis B.Semantic proximity Read ↗

Determination of hepatitis B phenotype using biochemical and serological markers.Semantic proximity Read ↗

How Effective Are Serum Scoring Systems in Predicting Liver Fibrosis Caused by Chronic Hepatitis B? Serum Scoring Systems and Liver FibrosisSemantic proximity Read ↗

Clinical significance of serum HBsAg levels and association with liver histology in HBeAg positive chronic hepatitis B.Semantic proximity Read ↗

Clinical significance of quantitative e antigen in a cohort of hepatitis B virus-infected children and adults in North America.Semantic proximity Read ↗

Development of hepatocellular carcinoma in chronic hepatitis B patients with advanced fibrosis is independent of viral genotype.Semantic proximity Read ↗

Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.Semantic proximity Read ↗

Serum hepatitis B core antibody titer use in screening for significant fibrosis in treatment-naïve patients with chronic hepatitis B.Semantic proximity Read ↗

Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients.Semantic proximity Read ↗

Different scores in assessing the severity and prognosis of HBV-related-a cute-on-chronic Liver FailureSemantic proximity Read ↗

The significance of hepatitis B virus (HBV) genotypes for the disease and treatment outcome among patients with chronic hepatitis B in Serbia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.